• Info
  • Insider Trading

Kevin Fitzgerald - Insider Trading & Ownership

Location
C/O Ovid Therapeutics Inc., 1460 Broadway, Suite 15044, New York, NY
Summary
The estimated net worth of Kevin Fitzgerald is at least $10.1M dollars as of November 19, 2025. Kevin Fitzgerald is the CSO & EVP, Head of Research of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $10.1M.
Signature
By: Brett Budzinski, Attorney-in-Fact For: Kevin Fitzgerald
All Insider Reports
All Insider Reports

Notify me when Kevin Fitzgerald files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Kevin Fitzgerald

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALNY ALNYLAM PHARMACEUTICALS, INC. CSO & EVP, Head of Research $10.1M -$8.54M -45.8% Nov 17, 2025
OVID Ovid Therapeutics Inc. Director Feb 20, 2025

Insider Transactions Reported by Kevin Fitzgerald:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.